X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (148) 148
humans (140) 140
oncology (130) 130
female (114) 114
middle aged (75) 75
aged (67) 67
breast cancer (56) 56
adult (55) 55
breast neoplasms - drug therapy (52) 52
chemotherapy (49) 49
antineoplastic combined chemotherapy protocols - therapeutic use (45) 45
breast neoplasms - pathology (40) 40
cancer (38) 38
male (34) 34
treatment outcome (34) 34
chemistry (30) 30
metallurgy (30) 30
beer (29) 29
biochemistry (29) 29
enzymology (29) 29
microbiology (29) 29
mutation or genetic engineering (29) 29
spirits (29) 29
vinegar (29) 29
wine (29) 29
aged, 80 and over (27) 27
prognosis (27) 27
neoplasm metastasis (25) 25
survival (25) 25
therapy (25) 25
care and treatment (23) 23
disease-free survival (22) 22
metastasis (22) 22
paclitaxel (22) 22
antineoplastic combined chemotherapy protocols - adverse effects (21) 21
hematology, oncology and palliative medicine (21) 21
medicine & public health (20) 20
compositions thereof (18) 18
culture media (18) 18
microorganisms or enzymes (18) 18
propagating, preserving or maintaining microorganisms (18) 18
breast neoplasms - metabolism (17) 17
apparatus for enzymology or microbiology (16) 16
combination (16) 16
paclitaxel - administration & dosage (15) 15
tumors (15) 15
animals (14) 14
antineoplastic agents - therapeutic use (14) 14
mutation (14) 14
neoplasm staging (14) 14
trastuzumab (14) 14
trial (14) 14
analysis (13) 13
breast neoplasms - mortality (13) 13
clinical trials (13) 13
doxorubicin (13) 13
drug administration schedule (13) 13
epirubicin - administration & dosage (13) 13
lung cancer (13) 13
ovarian neoplasms - drug therapy (13) 13
receptor, erbb-2 - metabolism (13) 13
1st-line treatment (12) 12
breast neoplasms - genetics (12) 12
carcinoma (12) 12
chemotherapy, adjuvant (12) 12
efficacy (12) 12
fluorouracil - administration & dosage (12) 12
metastatic breast cancer (12) 12
research (12) 12
women (12) 12
abridged index medicus (11) 11
cell biology (11) 11
docetaxel (11) 11
hematology (11) 11
human necessities (11) 11
hygiene (11) 11
medical or veterinary science (11) 11
phase-ii trial (11) 11
survival analysis (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
cancer therapies (10) 10
her2 (10) 10
infusions, intravenous (10) 10
obstetrics & gynecology (10) 10
preparations for medical, dental, or toilet purposes (10) 10
retrospective studies (10) 10
surgery (10) 10
antibodies, monoclonal, humanized (9) 9
biomarkers, tumor - metabolism (9) 9
breast neoplasms - surgery (9) 9
cisplatin (9) 9
deoxycytidine - analogs & derivatives (9) 9
drug therapy (9) 9
health aspects (9) 9
immunohistochemistry (9) 9
lung neoplasms - genetics (9) 9
lung neoplasms - pathology (9) 9
neoadjuvant therapy (9) 9
open-label (9) 9
patient outcomes (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 6, pp. 523 - 533
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1594 - 1600
Journal Article
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2010, Volume 122, Issue 1, pp. 181 - 188
Long-term bisphosphonate therapy is associated with increased risk of osteonecrosis of the jaw (ONJ). In a retrospective analysis, a 16% ONJ incidence was... 
Angiogenesis | Bisphosphonate | Medicine & Public Health | Osteonecrosis of the jaw | Oncology | Metastatic breast cancer | Bevacizumab | MULTIPLE-MYELOMA | RISK-FACTORS | EFFICACY | BONE METASTASES | PREVENTION | ONJ | ONCOLOGY | PROSTATE-CANCER | EXPERIENCE | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Osteonecrosis - epidemiology | Humans | Jaw Diseases - prevention & control | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Incidence | Jaw Diseases - chemically induced | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Diphosphonates - adverse effects | Multicenter Studies as Topic - statistics & numerical data | Randomized Controlled Trials as Topic - statistics & numerical data | Double-Blind Method | Jaw Diseases - epidemiology | Breast Neoplasms - drug therapy | Oral Hygiene | Drug Synergism | Breast Neoplasms - complications | Taxoids - administration & dosage | Breast Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Genes, erbB-2 | Aged | Osteonecrosis - chemically induced | Osteonecrosis - prevention & control | Care and treatment | Analysis | Phosphonates | Clinical trials | Bones | Breast cancer | Angiogenesis inhibitors | Health aspects | Necrosis | Index Medicus
Journal Article
The Oncologist, ISSN 1083-7159, 10/2016, Volume 21, Issue 10, pp. 1161 - 1162
In Central and Western Europe, cancer mortality is declining at slower rates as compared with rates in the rest of the world. More than a generation has now... 
MORTALITY | AMERICA | ONCOLOGY | GAP | PREDICTIONS | PATTERNS | UPDATE | TRENDS | DECLINE | Europe, Eastern | Neoplasms - prevention & control | Europe | Humans | Index Medicus
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2018, Volume 168, Issue 1, pp. 127 - 134
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 05/2019, Volume 9, Issue 1, pp. 7154 - 12
Tumors develop within complex cell-to-cell interactions, with accessory cells playing a relevant role starting in the early phases of cancer progression. This... 
MULTIDISCIPLINARY SCIENCES | CELL-CULTURE | TUMOR-MODELS | Adenocarcinoma | Cell culture | Sarcoma | Tumor cells | Lung cancer | Glioblastoma | Cytotoxicity | Tumor cell lines | Cell interactions | Chemotherapy | Immune checkpoint | Bioreactors | Accessory cells | Gene therapy | Pancreas | Cancer | Tumors
Journal Article